Trevi Therapeutics's market cap is currently $428.96M. The company's EPS TTM is $-0.441; its P/E ratio is ―; Trevi Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -123.00K	$ -43.00K	$ -50.00K	$ -47.00K	$ -39.00K
Operating Income	$ -33.92M	$ -29.91M	$ -32.48M	$ -32.49M	$ -26.64M
EBITDA	$ -33.80M	$ -29.86M	$ -32.43M	$ -32.44M	$ -26.61M
Net Income	$ -29.07M	$ -29.15M	$ -33.94M	$ -32.76M	$ -26.05M
Balance Sheet
Cash & Short-Term Investments	$ 82.97M	$ 12.59M	$ 36.83M	$ 45.00M	$ 57.31M
Total Assets	$ 89.40M	$ 123.02M	$ 38.48M	$ 47.13M	$ 60.00M
Total Debt	$ 1.34M	$ 9.18M	$ 14.63M	$ 14.21M	$ 356.00K
Net Debt	$ -31.06M	$ -3.41M	$ -22.20M	$ -30.79M	$ -56.96M
Total Liabilities	$ 6.86M	$ 15.56M	$ 21.40M	$ 19.85M	$ 5.46M
Stockholders' Equity	$ 82.55M	$ 107.46M	$ 17.07M	$ 27.28M	$ 54.55M
Cash Flow
Free Cash Flow	$ -31.85M	$ -28.33M	$ -28.95M	$ -29.03M	$ -23.10M
Operating Cash Flow	$ -31.71M	$ -28.18M	$ -28.95M	$ -29.00M	$ -23.09M
Investing Cash Flow	$ 59.43M	$ -107.37M	$ 0.00	$ -32.00K	$ -9.00K
Financing Cash Flow	$ -7.91M	$ 111.31M	$ 20.77M	$ 16.72M	$ 73.21K

Currency in USD

Trevi Therapeutics Earnings and Revenue History

Income Statement >

Trevi Therapeutics Debt to Assets

Balance Sheet >

Trevi Therapeutics Cash Flow

Cash Flow >

Trevi Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing